Literature DB >> 24199799

Epidemiology of whooping cough & typing of Bordetella pertussis.

Nicolas Hegerle1, Nicole Guiso.   

Abstract

Bordetella pertussis is a Gram-negative human-restricted bacterium that evolved from the broad-range mammalian pathogen, Bordetella bronchiseptica. It causes whooping cough or pertussis in humans, which is the most prevalent vaccine-preventable disease worldwide. The introduction of the pertussis whole-cell vaccination for young children, followed by the introduction of the pertussis acellular vaccination (along with booster vaccination) for older age groups, has affected the bacterial population and epidemiology of the disease. B. pertussis is relatively monomorphic worldwide, but nevertheless, different countries are facing different epidemiological evolutions of the disease. Although it is tempting to link vaccine-driven phenotypic and genotypic evolution of the bacterium to epidemiology, many other factors should be considered and surveillance needs to continue, in addition to studies investigating the impact of current clinical isolates on vaccine efficacy.

Entities:  

Mesh:

Year:  2013        PMID: 24199799     DOI: 10.2217/fmb.13.111

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  10 in total

1.  Follow-Up of External Quality Controls for PCR-Based Diagnosis of Whooping Cough in a Hospital Laboratory Network (Renacoq) and in Other Hospital and Private Laboratories in France.

Authors:  Sophie Guillot; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2016-05-18       Impact factor: 5.948

2.  Acellular Pertussis Vaccine Effectiveness Over Time.

Authors:  Ousseny Zerbo; Joan Bartlett; Kristin Goddard; Bruce Fireman; Edwin Lewis; Nicola P Klein
Journal:  Pediatrics       Date:  2019-06-10       Impact factor: 7.124

3.  The impact of past vaccination coverage and immunity on pertussis resurgence.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Sci Transl Med       Date:  2018-03-28       Impact factor: 17.956

4.  Intention to accept pertussis vaccination among Chinese people older than age 5.

Authors:  Xuewen Tang; Tingting Tang; Rui Yan; Yang Zhou; Xuan Deng; Hanqing He
Journal:  Hum Vaccin Immunother       Date:  2021-01-15       Impact factor: 3.452

5.  The characterization of Bordetella pertussis strains isolated in the Central-Western region of Brazil suggests the selection of a specific genetic profile during 2012-2014 outbreaks.

Authors:  E L Rocha; D Leite; C H Camargo; L M Martins; R S N Silva; V P Martins; T A Campos
Journal:  Epidemiol Infect       Date:  2017-02-21       Impact factor: 4.434

6.  Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.

Authors:  M van Gent; C J Heuvelman; H G van der Heide; H O Hallander; A Advani; N Guiso; C H Wirsing von Kőnig; D F Vestrheim; T Dalby; N K Fry; D Pierard; L Detemmerman; J Zavadilova; K Fabianova; C Logan; A Habington; M Byrne; A Lutyńska; E Mosiej; C Pelaz; K Gröndahl-Yli-Hannuksela; A M Barkoff; J Mertsola; A Economopoulou; Q He; F R Mooi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-20       Impact factor: 3.267

7.  Clinical detection of human probiotics and human pathogenic bacteria by using a novel high-throughput platform based on next generation sequencing.

Authors:  Chih-Min Chiu; Feng-Mao Lin; Tzu-Hao Chang; Wei-Chih Huang; Chao Liang; Ting Yang; Wei-Yun Wu; Tzu-Ling Yang; Shun-Long Weng; Hsien-Da Huang
Journal:  J Clin Bioinforma       Date:  2014-01-13

8.  Fha Deficient Bordetella pertussis Isolates in Iran with 50 Years Whole Cell Pertussis Vaccination.

Authors:  Samaneh Saedi; Azadeh Safarchi; Faranak Tayebzadeh Moghadam; Siamak Heidarzadeh; Vajihe Sadat Nikbin; Fereshteh Shahcheraghi
Journal:  Iran J Public Health       Date:  2021-07       Impact factor: 1.429

9.  New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates.

Authors:  Valérie Bouchez; Nicolas Hegerle; Francesco Strati; Elisabeth Njamkepo; Nicole Guiso
Journal:  Vaccines (Basel)       Date:  2015-09-14

10.  Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model.

Authors:  Marta Prygiel; Ewa Mosiej; Karol Wdowiak; Paulina Górska; Maciej Polak; Klaudia Lis; Katarzyna Krysztopa-Grzybowska; Aleksandra Anna Zasada
Journal:  Med Microbiol Immunol       Date:  2021-08-02       Impact factor: 3.402

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.